Tiotropium: Side Effects, Uses & Monitoring
Facts extracted from current FDA product labeling for Tiotropium. Educational only — not medical advice.
Labeled uses
SPIRIVA HANDIHALER (tiotropium bromide inhalation powder) is indicated for the long-term, once-daily, maintenance treatment of bronchospasm associated with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and emphysema. SPIRIVA HANDIHALER is indicated to reduce exacerbations in COPD patients.
Source: FDA labeling via NIH DailyMed (set 25a4cb05…). Not affiliated with FDA or NIH.
Medical disclaimer: Always consult a qualified healthcare professional about any medication.